Gut microbiota as one of the key regulators of metabolic diseases

Author:

Kostyuchenko L. N.1ORCID,Vasina T. A.2ORCID,Lychkova A. E.1ORCID

Affiliation:

1. Loginov Moscow Clinical Scientific Center

2. Sklifosovsky Research Institute For Emergency Medicine

Abstract

Introdiction. The presence of obesity in a patient or, conversely, malnutrition is accompanied by various metabolic disorders and is the focus of modern medical science and healthcare organizers.Objective. To reveal the mechanism of action (impact on motility through the intestinal microbiota) of the drug mebeverine in the structure of concomitant therapy for IBS.Material and methods. The index of nutritional insufficiency was proposed and calculated by us on the basis of the parameters of the alimentary-volemic diagnosis, expressed in points; up to 29 points – a mild degree of nutritional deficiency (the risk of surgery is minimal, the operation is possible after a short-term infusion preparation); 29–30 points – medium degree (the risk is relatively high, the operation is possible only after at least minimal preliminary infusion-alimentation correction); 31–33 – severe degree of nutritional insufficiency (the risk of surgery is high, surgery can only be performed in an emergency after minimal preparation or planned after a long preparation of the patient for surgery until the nutritional status is increased by 1–2 levels; 34–42 – extremely severe (only emergency surgery or palliative after preliminary preparation, raising, if possible, the nutritional status by 1–2 levels).Rehabilitation potential was determined according to generally accepted formulas. Microbiota was also determined by the traditional method. Electrical activity and the nature of motility were determined by it using a mingograph.Results and discussion. During the examination, it was revealed that the microbiota differs with different HN. At 29–30 points, HH and high RR occur. Rehabilitation potential (RP) has 4 levels of assessment: High rehabilitation potential implies the possibility of achieving a full recovery of healthConclution. Gut microbiota is a key regulator of metabolic disease. When taking mebeverine, it is advisable. Apparently, to apply a detoxification correction, because it is metabolized in the liver. There is no doubt that it is expedient to further study the state of the microbiota in the modern world with various TIN.

Publisher

Remedium, Ltd.

Subject

General Medicine

Reference30 articles.

1. Koshimbetova G.K., Kutlimuratova Z.R. Irritable bowel syndrome as an aspect of functional diseases of the gastrointestinal tract. Medicus. 2019;(2):35–37. (In Russ.) Available at: https://elibrary.ru/item.asp?id=39385763.

2. Andreev D.N. The role of alterations in permeability of the intestinal mucosa in the genesis of functional gastrointestinal disorders. Consilium Medicum. 2019;21(8):29–34. (In Russ.) Available at: https://consilium.orscience.ru/2075-1753/article/view/96779.

3. Stepanov Yu.M., Fedorova N.S., Zigalo E.V. The effectiveness of rifaximin in the correction of bacterial overgrowth syndrome in chronic inflammatory and functional bowel diseases. Gastroenterology (Ukraine). 2019;53(4):246–251. (In Ukr.) Available at: https://cyberleninka.ru/article/n/effektivnost-rifaksimina-v-korrektsii-sindroma-izbytochnogo-bakterialnogo-rosta-pri-hronicheskih-vospalitelnyh-i-funktsionalnyh.

4. Andreev D.N., Dicheva D.T. A breach in the intestinal permeability as a factor of etiopathogenesis of functional gastrointestinal diseases. Meditsinskiy Sovet. 2020;(5):87–95. (In Russ.) https://doi.org/10.21518/2079-701X-2020-5-87-95.

5. Minushkin O.N., Maslovskiy L.V., Bulanova M.I., Gordienko E.S., Topchiy T.B., Beylina N.I. Experience of using metaprebiotics in the treatment of certain functional gastrointestinal disorders. Meditsinskiy Sovet. 2020;(15):105–111. (In Russ.) https://doi.org/10.21518/2079-701X-2020-15-105-111.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3